Refills are Not retention in independent pharmacy

Your best patients are being recruited right now.

Bryan Wheeler, an independent pharmacist writing in Drug Topics, broke down how the Medicare GLP-1 Bridge is changing pharmacy operations. Adam Fein's Drug Channels Institute added a new section to the 2026 Economic Report on manufacturer direct-to-patient websites. As of late last year, Lilly said LillyDirect was filling more than a third of new Zepbound prescriptions. TrumpRx, the federal price portal that routes patients to manufacturers' own direct-to-consumer sites, has been live since February.

The chain pharmacy across the street was the last decade's threat.

This is the next one.

A manufacturer with a landing page, a copay assistance program, a home delivery contract, and a patient portal that already knows the patient's medication history. No counter, no line, no local relationship required.

That's what's pulling on your best patients right now.

The False Comfort

Most independent pharmacy owners have already told themselves the same thing about this trend.

My patients will stay because they know me.

My patients trust my team.

My patients have been coming here for years.

All of that may be true.

And none of it is a retention system.

The 2025 NCPA Digest reported the average independent pharmacy filled 67,601 prescriptions in 2024. Sales hit a ten-year high that year. So did the cost of goods. Gross profits hit a ten-year low.

Volume is not a relationship.

Refills are not retention.

A busy pharmacy can still be a fragile business.

The Real Mechanism

Patients don't leave making a lot of noise.

They fill one prescription somewhere else because it was convenient that week. They accept a manufacturer coupon that comes with automatic ninety-day mail delivery. Their spouse signs them up for a direct-to-patient program that arrived in the mailbox the same day their doctor sent an electronic prescription somewhere else. Their caregiver switches them to a service that syncs with the specialty prescriber.

By the time you notice, the drift has been happening for six months.

That drift is the most expensive tax in independent pharmacy. It gets paid every single month, and you never see the invoice.

It's called retention leakage.

The Frame That Fixes It

The pharmacies that keep the patients others lose have stopped thinking about retention as a feeling. They think about it as a rhythm.

They've named the cohort they can't afford to lose. Their top prescribers' patients. Their high-complexity patients. Their families. Their caregivers.

Then they built a weekly cadence around that cohort instead of a mass campaign, a repeating pattern of small, meaningful contacts that make the patient feel seen and expected between prescriptions.

A monthly Patient Connection Letter. A retention touch when a refill window slips. A reactivation contact when a patient goes quiet. 

None of this requires a new marketing budget. It requires a Cadence, a named team member who runs the rhythm every week, so the retention behaviors don't depend on the owner remembering to remember.

That's what preeminence looks like on a Tuesday afternoon.

Being known. Being useful. Being remembered. Being harder to replace.

What This Costs When It Isn't Installed

In my own pharmacy, I mailed a monthly direct response customer newsletter to my high value VIP customers for eighty-four straight months. Its job was to stay in the patient's life between prescriptions. Caregivers read it. Patients shared it. Families asked us about articles at the counter.

I didn't build that habit because I was disciplined. I built it because I learned early that patients you never contact between prescriptions are patients you're losing to whoever else contacts them.

Every independent pharmacy has this asset.

Most under-activate it every week.

The Next Eighteen Months

The next twelve to eighteen months will separate the independent pharmacies that installed a weekly retention cadence from the ones that kept hoping the patients they trained would stay by default.

Direct-to-patient programs aren't slowing down. Manufacturer portals aren't going away. Federal price portals aren't shrinking.

The question isn't whether your best patients will be recruited away from you.

They already are.

The question is whether your pharmacy has a weekly cadence built to keep them.